Decipher Labs Ltd

Decipher Labs Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct. The trading window will be shut from July 1, 2026, until 48 hours after the declaration of financial results for the quarter ending June 30, 2026. This restriction applies to all designated persons, their immediate relatives, and connected persons. The company will inform the exchange in due course about the date of the Board Meeting scheduled to approve these financial results.

Decipher Labs Ltd's board meeting on May 30, 2026, approved audited financial results for the quarter and year ended March 31, 2026. The company reported revenue from operations of ₹113.58 lakhs and a loss of ₹24.68 lakhs for the year ended March 31, 2026. The auditors, M/s. Ramanathan & Rao, issued an unmodified opinion on the standalone and consolidated financial results. The company's assets totaled ₹899.52 lakhs as of March 31, 2026.

Decipher Labs Limited announced audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board of Directors approved these results in a meeting held on May 30, 2026. The company reported a loss of ₹24.68 lakhs for the year ended March 31, 2026, and revenue from operations of ₹113.58 lakhs. The auditors, M/s. Ramanathan & Rao, issued an unmodified opinion on the financial results.

Decipher Labs Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2026, along with the audit report (standalone and consolidated) for the same period. The meeting will also address any other business with the permission of the Chair.

Decipher Labs Ltd has announced the closure of its trading window for the period ending on 31st March, 2026. The trading window will remain closed for all designated persons, their immediate relatives, and all connected persons covered under the Company's Code of Conduct from 01.04.2026 till 48 hours after the declaration of financial results for the year ended 31.03.2026. The date of the Board Meeting for the declaration of financial results will be intimated in due course.

Decipher Labs Ltd, a pharmaceutical company, has reported its unaudited financial results for the quarter and nine months ended 31st December 2025. The company's profit before tax for the segment 'Manufacturing and Trading of Pharmaceutical drugs' has decreased by 43.90% compared to the same period last year. The company's total comprehensive income for the year is (44.02) Lakhs. The financial results have been prepared in accordance with Ind AS and the New Labour Codes, which are effective from November 21, 2025.

Decipher Labs Ltd. announced the financial results for the quarter and nine months ended 31st December 2025. The company's revenue from operations stands at ₹ 322.81 crores for the quarter and ₹ 597.34 crores for the nine months period. The total expenses for the quarter are ₹ 64.10 crores and ₹ 2,139.16 crores for the nine months period. The profit before tax for the quarter is ₹ 1,045.00 crores and ₹ 1,911.24 crores for the nine months period. The company's operations relate to two segments: Manufacturing and Trading of Pharmaceutical drugs and Consultancy Services. The financial results were reviewed by the Audit Committee and approved by the Board of Directors on 12th February 2026.

Decipher Labs Ltd has informed the BSE that its Board of Directors will meet on February 12, 2026, to consider and approve the un-audited financial results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2025. The meeting will also consider the Limited Review Report (Standalone and Consolidated) for the quarter ending December 31, 2025. Any other business with the permission of the Chair will also be discussed.

Decipher Labs Ltd has called for an Extra-Ordinary General Meeting (EGM) on 12th February 2026 to appoint Mr. Dalavath Amar Singh as a Director and Whole-Time Director. The EGM will be held through Video Conference / Other Audio-Visual Means (VC/OAVM) facility. The cut-off date for e-voting is 5th February 2026. Mr. Singh was appointed as an Additional Director (Category: Executive Director) on 13th November 2025 and his appointment as a Director is subject to the approval of the shareholders at the EGM.

Decipher Labs Limited held a Board meeting on 19.01.2026 at its registered office. The Board approved the notice of an Extra-Ordinary General Meeting scheduled for 12% February, 2026 at 11.00 a.m. through video conference or other audio-visual means. The Board also appointed M/s. S.S. Reddy & Associates, Practicing Company Secretaries as Scrutiniser to the Extra-Ordinary General Meeting.